Latest News

Find out what’s going on within Adelphi Values. Use the filters below to help find content more specific to your interests.

On Wednesday 15th October, Eimear Nic Lochlainn and Jennifer Cook from the Adelphi Values Value Insight & Communication practice presented a master class in association with SMI at the European Pharmaceutical Pricing and Reimbursement conference in London. Targeted at pharmaceutical executives and senior market access professionals, the master class provided… Read More

Announcing a newly created global leadership team and growth in our senior management team with three new recruits in recent weeks. Established in 1993, Adelphi Values has been a global leader in patient-centered and healthcare value research for over 20 years. Throughout this time, we have expanded our offering to… Read More

On Monday, April 21st 2014, Gina from our US office ran the Boston Marathon as part of the Dana-Farber Marathon Challenge (DFMC) team.  This is her story: DFMC runners include cancer survivors and patients, as well as family and friends of those who have been affected by cancer.  It’s a truly… Read More

Cheryl Coon, Associate Director from our Endpoint Development & Outcomes Assessment practice will be presenting at the DIA 2014 50th Annual Meeting in San Diego on June 19th. The session titled ‘Moving Beyond the Traditional Psychometric Validation of New Phase 3 Clinical Outcome Assessments’ will be on June 19, 9:00AM… Read More

A big thank you from Adelphi and Unicef

In December 2013, the Adelphi group of companies came together for the second year running to send out a Season’s Greetings message, not only to wishing recipients well for 2014, but also providing an opportunity to nominate an Adelphi donation to one of three possible initiatives: WATER PUMP FOR A… Read More

We are delighted to report that on February 18 2014, Chelsea Therapeutics announced that the US Food and Drug Administration (FDA) granted accelerated approval of NortheraTM (Droxidopa) for the treatment of symptomatic neurogenic hypotension (NOH).  Not only is this the first new treatment for NOH in nearly… Read More

This week, employees from Adelphi Values have joined forces with the other Adelphi Group companies based in the UK office, to raise funds and awareness for Sport Relief – a UK charity event from 21 – 23 March. The team has been participating in the Adelphi Group ‘Step Out for… Read More

On July 29th Adelphi Values will move to Atlantic Wharf – a building recognized last year as Boston’s first ‘green’ skyscraper.  The 1.2 million square-foot mixed-use project made the headlines in 2012 when Boston Properties received the Global Award for Excellence from the Urban Land Institute for the restored historic… Read More

To meet the evolving needs of our clients, Adelphi Values has recruited two additional Directors with extensive experience of working in the EU, US and Asian payer environments. This further increases the capability to help our clients address the needs of public and private payers at the local and national… Read More